m+Medelevator.RU
← Поиск публикаций
Journal of pharmacy & bioallied sciences · 2025

Study the Correlation between Serum Caspase-1, IL-10, HOMA-IR, FAI, Dyslipidemia, and Oxidative Stress Status in Women with Polycystic Ovary Syndrome (PCOS).

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Gusain Neelam, Anjankar Ashish P, Ambad Ranjit S, Jha Roshan K, Jha Rakesh

Аннотация

INTRODUCTION: Polycystic Ovary Syndrome (PCOS) is a major health concern for women worldwide, particularly those of childbearing age. PCOS is a common endocrine disorder that has widely known reproductive, metabolic, cardiovascular adverse effects that lead to significant morbidity. There is continued research into the nature of this disorder and still many gaps to fill in the understanding of the exact ways in which PCOS develops.

MATERIALS AND METHODS: This study aims to investigate this uncharted horizon of PCOS by analysing the association between serum Caspase-1, IL-10, and biochemical indices relative to insulin resistance (HOMA-IR), hyperandrogenism (FAI), dyslipidemia, and oxidative stress in our female population. It expands on the significance of inflammation and insulin resistance, together with dyslipidemia, in the advancement and signs and symptoms of PCOS. Given the dearth of research that has explored the relationship between Caspase-1 and IL-10 in Indian women with established PCOS, this research preserves a central position. Its goal to improve the knowledge of the disease's inflammatory and metabolic mechanisms and promote biomarkers and therapeutic targets discovery. The preface to this work in emphasizing the desire to contribute to medical science in its capacity to treat disease patients, in arguing that interdisciplinary collaboration between biochemistry, endocrinology, and gynaecology to improve to patient care.

EXPECTED OUTCOME: Our goal is to reveal possible approaches to reduce the impact of PCOS to improve the outcomes of its diagnostic, treatment and preventive methodologies for millions of afflicted women.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты